Company Performance: The company's financial health, including revenue, profit, and debt levels, significantly impacts investor confidence and stock price. Strong performance typically leads to higher prices.

Industry Trends: The overall performance and outlook of the pharmaceutical industry influence investor sentiment towards the stock. Positive industry trends often drive stock prices upward.

Regulatory Environment: Government regulations, particularly those related to drug approvals, pricing, and healthcare policies, can have a substantial impact on the company's operations and stock price.

Market Sentiment: General investor optimism or pessimism about the stock market and the Chinese economy can influence trading activity and stock prices.

Competitor Actions: The actions of competitors, such as new drug launches or acquisitions, can affect the company's market share and stock price.

Macroeconomic Factors: Economic indicators like interest rates, inflation, and GDP growth can influence investment decisions and the overall stock market, affecting the company's stock price.

Specific Company News: Announcements about clinical trial results, product launches, partnerships, or management changes can trigger significant price movements.

Global Events: International events, such as global health crises or trade disputes, can impact investor sentiment and supply chains, affecting the company's stock price.

Shareholder Structure: Major changes in ownership or institutional investor activity can influence supply and demand for the stock and affect its price.